Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean naphazoline hydrochloride and pheniramine maleate?
Displaying drugs 14126 - 14150 of 14586 in total

Clofibride

Experimental

Bisoxatin acetate

Experimental

Motexafin lutetium

Motexafin lutetium (MLu) is a second-generation photosensitizer for photodynamic therapy (PDT) of cancer. It belongs to the family of drugs called metallotexaphyrins. Also called lutetium texaphyrin. Motexafin lutetium is a pentadentate aromatic metallotexaphyrin with photosensitizing properties.
Investigational

DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME)

Experimental

Talviraline

Talviraline has been used in trials studying the treatment of HIV Infections.
Investigational

4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL

Experimental

3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME

Experimental

Piclozotan

Piclozotan has been investigated for the treatment of Parkinson's Disease.
Investigational

Mephenoxalone

Experimental

Rose bengal lactone

Experimental

Candoxatril

Candoxatril is the orally-active prodrug of candoxatrilat (UK-73967), a potent neutral endopeptidase (NEP) inhibitor.
Experimental

A-98881

Experimental

6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid

Experimental

N-[Tosyl-D-Prolinyl]Amino-Ethanethiol

Experimental

(7R)-7-(6,7-Dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid

Experimental

(2R)-2-{(1R)-2-oxo-1-[(2-thienylacetyl)amino]ethyl}-5,6-dihydro-2h-1,3-thiazine-4-carboxylic acid

Experimental

4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL

Experimental

(5S)-2-{[(1S)-1-(4-Fluorophenyl)ethyl]amino}-5-(2-hydroxy-2-propanyl)-5-methyl-1,3-thiazol-4(5H)-one

Experimental

BMS-564929

BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental

CCT-018159

Experimental

2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID

Experimental

(S)-famoxadone

Experimental

SD-0006

Investigational

MK-4965

MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental

Reproxalap

Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Description: … Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and …
Displaying drugs 14126 - 14150 of 14586 in total